OncoLux Inc.

See the Unseen….

Treat the Unseen….

In-Situ

See the Unseen…

Treat the Unseen…

In-Situ

Introducing the OncoLux

LUMIS™ Optical Theranostic Platform

Combing In-situ optical enhanced imaging and photodynamic therapy, enabling both Diagnostic and Therapeutic capabilities in one device, enabling “See and Treat” capability.

Tumor Imaging

Current Bench-Top Ex-Vivo Biopsy Fluorescence Imaging System

Future
“Flexible-Endo”
Fluorescence Imaging System

Novel Light Applicator Device and Light Dosimetry System

  • Simple, Fast, Precise, Repeatable PDT Outcomes
  • Use of 5-ALA (Gleolan®)- an FDA approved agent with an established safety profile
  • No systemic toxicities or side effects, minimal damage to healthy tissue
  • Clinically proven in minimally invasive procedures including VATS and robotic-assisted laparoscopy
Scroll to Top